CORE LABORATORY
Don't have an account? Sign Up

Integrating Hematology and Coagulation Results to Enhance Diagnosis

Overview

Dr. Larry Smith discusses three cases that share abnormal findings across both disciplines. These abnormal findings, taken together, aid in an enhanced diagnosis to help the clinician deliver improved patient outcomes.

Speaker

Larry Smith, PhD
Manager, Medical & Scientific Affairs, Abbott (Retired)

 

Objectives
  • Describe the pathogenesis of Acute Promyelocytic Leukemia (APL), Chronic Lymphocytic Leukemia (CLL) and Thrombotic Thrombocytopenic Purpura (TTP)
  • Review the hematological profile of APL, CLL and TTP cases
  • Outline mechanisms associated with the coagulopathy in APL, CLL and TTP
  • Describe the need for both hematology and coagulation in the diagnoses of APL, CLL and TTP
WATCH NOW

YOU MAY ALSO LIKE

Advancements in WBC Differential Technology

Don Wright discusses the general principles of automated WBC and differential technology, processing limitations associated with available options, and discuss key technology trends.
ADD TO LEARNING PLAN

Quality Assurance in the Hematology Laboratory

Sten Westgard discusses some of the current quality control (QC) practices in hematology, and adopt QC best practices to optimize the "Westgard Rules" for hematology parameters.
ADD TO LEARNING PLAN

Laboratory Diagnosis of von Willebrand Disease

Dr. Larry Smith discusses the history of von Willebrand Disease (vWD), touch on current classification, review the structure of von Willebrand Factors, and finally go over methods/technologies for diagnosing vWD.
ADD TO LEARNING PLAN

CONTRIBUTORS

Contributor
Larry Smith, PhD (Retired)
BIO
©2021 Abbott, Abbott Park, Illinois, U.S.A.

Privacy Policy| Terms and Conditions

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All Alinity hq, CELL-DYN Ruby and CELL-DYN Sapphire instruments are Class I laser products. ACCELERATOR a3600 is a Class II laser product. 

The Alinity, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully. Manufacturer or Authorized Representative: Abbott Germany.

Alinity h-series is available in select countries, not including the US.